ACI Life Sciences Patents Conference

DoubleTree Suites by Hilton Times Square
New York City, NY
Comprehensive and Practical Prosecution and Non-Hatch-Waxman Litigation Strategies for Biotechnology, Pharmaceutical, and Diagnostics Companies.

As a part of the American Conferences Institute IP workshop series, Sughrue partner John Callahan will participate in the panel discussion, “Strategies for Avoiding of Overcoming the growing Reach of Obviousness-Type Double Patenting." The program will examine the pitfalls facing corporations with earlier-filed but later issued patents post Gilead Sciences Inc. v. Natco Pharma, Ltd., methods for conducting ODP analysis and prospective, practical strategies for avoiding or arguing against double patenting. For more information, or to register for this event, please click here.